BioPharmSignal logoBioPharmSignal

Biotech News

Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook

Sientra (SIEN)SientraEarnings

SIEN (SIEN) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is sien.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

RXSTRxSight2026-07-06 20:15 EST

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

RXSTRxSight2026-08-05 20:05 EST

RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook

CVRXCVRx2026-08-06 20:05 EST

CVRx Reports Second Quarter 2026 Financial and Operating Results

PLSEPulse Biosciences2026-08-06 20:05 EST

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

DNLIDenali Therapeutics2026-08-06 20:01 EST

Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

SHCSotera Health2026-08-06 11:00 EST

Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

AEMDAethlon Medical2026-08-05 12:01 EST

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

ACHCAcadia Healthcare2026-07-28 20:05 EST

Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

DNLIDenali Therapeutics2026-07-27 20:01 EST

Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026

View all latest news

Sientra

Sientra was a medical aesthetics company focused on breast implants and related surgical products before being acquired. Its story was rooted in device and procedure demand rather than drug development.

Recent company news

SIENSientra2024-04-02 22:30 EST

Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction

SIENSientra2024-02-13 13:30 EST

Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

SIENSientra2023-11-09 21:05 EST

Sientra Reports Third Quarter Financial and Operational Results

SIENSientra2023-11-08 13:35 EST

Sientra to Present at the Stifel 2023 Healthcare Conference

SIENSientra2023-10-30 21:00 EST

Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
MedTech
Location
United States